|
|
Article: Manhattan Pharmaceuticals To Present Safety Data for Propofol Lingual Spray at the 79th Clinical and Scientific Congress of the International Anesthesia Research Society.
- Article from:
- Business Wire
- Article date:
- March 15, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK -- Manhattan Pharmaceuticals, Inc. ("Manhattan") (OTCBB: MHTT), is scheduled to present positive safety data on its proprietary sedative, Propofol Lingual Spray, at the 79th Clinical and Scientific Congress of the International Anesthesia Research Society, at the Hilton Hawaiian Village in Honolulu, March 15, 2005.
In a presentation entitled, "Pilot Safety, Tolerability, and Pharmacokinetic Human Trial of Propofol Lingual Spray," Bina Tejura, Manhattan's Assistant Chief Medical Officer, will present results regarding the safety, tolerability and blood levels of Propofol Lingual Spray after lingual spray administration to healthy adults in Manhattan's ...